(Q37771070)

22 August 2017

1 reference

title

Behavioral complications of drug treatment of Parkinson's disease (English)

1 reference

22 August 2017

1 reference

Cummings JL

1

1 reference

PubMed ID

2061539

22 August 2017

language of work or name

English

0 references

publication date

1 July 1991

1 reference

Journal of the American Geriatrics Society

22 August 2017

1 reference

22 August 2017

39

1 reference

22 August 2017

708-716

1 reference

22 August 2017

7

1 reference

L-dopa long-term treatment in Parkinson's disease: age-related side effects.

22 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Adverse effects of antiparkinsonian drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Mental symptoms in parkinsonism following benzhexol hydrochloride therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Visual Hallucinations and Delirium During Treatment with Amantadine (Symmetrel)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Treatment of Parkinsonism with Laevo-Dopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

The prevalence and aetiology of long-term L-dopa side-effects in elderly parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Parkinson's disease: a comparison of mesulergine and bromocriptine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Combined bromocriptine-levodopa therapy early in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Pergolide in late-stage Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Subcutaneous apomorphine in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Amphetamines in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Bupropion in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Levodopa-induced psychosis: a kindling phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Psychosis and Other Psychiatric Manifestations of Levodopa Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Mental effects of high-dosage levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Effects of levodopa in Parkinsonian patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Mental symptoms in Parkinsonian patients treated with L-dopa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Clozapine treatment of psychosis in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Clozapine for psychosis in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Psychiatric Side Effects of Levodopa in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Emotional functions in short-term vs. long-term L-Dopa therapy in Parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Akathisia in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Serial cognitive profiles in levodopa-induced hypersexuality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Hypersexuality or altered sexual preference following brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Dopa dose-dependent sexual deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Confusion, dementia and anticholinergics in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Bromocriptine-induced mania?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Bromocriptine-related psychosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1991.TB03627.X

10.1111/J.1532-5415.1991.TB03627.X

21 January 2018

Identifiers

DOI

1 reference

release_72gnuzcjzneorokiq7pw6blyoy

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/72gnuzcjzneorokiq7pw6blyoy

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

2061539

1 reference

PubMed ID

2061539